Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Thomas MaCurdy"'
Autor:
Yixin Jiao, Keran Moll, Graça M. Dores, Ellen Tworkoski, Cindy Ke Zhou, Dorothy Scott, Hui‐Lee Wong, Kathryn Fingar, Timothy Burrell, Rowan McEvoy, Shayan Hobbi, Yoganand Chillarige, Joyce Obidi, Thomas MaCurdy, Jeffrey Kelman, Azadeh Shoaibi
Publikováno v:
Transfusion. 63:516-530
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4729430eaeda24897b6cc9f985d4fb6f
https://doi.org/10.1111/trf.17261
https://doi.org/10.1111/trf.17261
Autor:
Keran, Moll, Bradley, Lufkin, Kathryn R, Fingar, Cindy, Ke Zhou, Ellen, Tworkoski, Chianti, Shi, Shayan, Hobbi, Mao, Hu, Minya, Sheng, Jillian, McCarty, Shanlai, Shangguan, Timothy, Burrell, Yoganand, Chillarige, Jeff, Beers, Patrick, Saunders-Hastings, Stella, Muthuri, Kathryn, Edwards, Steven, Black, Jeff, Kelman, Christian, Reich, Kandace L, Amend, Djeneba Audrey, Djibo, Daniel, Beachler, Rachel P, Ogilvie, Alex, Secora, Cheryl N, McMahill-Walraven, John D, Seeger, Patricia, Lloyd, Deborah, Thompson, Rositsa, Dimova, Thomas, MaCurdy, Joyce, Obidi, Steve, Anderson, Richard, Forshee, Hui-Lee, Wong, Azadeh, Shoaibi
Publikováno v:
Vaccine. 41:333-353
The U.S. Food and Drug Administration (FDA) Biologics Effectiveness and Safety (BEST) Initiative conducts active surveillance of adverse events of special interest (AESI) after COVID-19 vaccination. Historical incidence rates (IRs) of AESI are compar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8aef7bb5020f78a013080315d163c66
https://doi.org/10.1016/j.vaccine.2022.11.003
https://doi.org/10.1016/j.vaccine.2022.11.003
Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years
Autor:
Patricia C. Lloyd, Mao Hu, Hui-Lee Wong, Azadeh Shoaibi, Cindy Ke Zhou, An-Chi Lo, Kandace Amend, Daniel C. Beachler, Cheryl N. McMahill-Walraven, Elizabeth R. Smith, John Seeger, Alex Secora, Djeneba Audrey Djibo, Joyce Obidi, Yuhui Feng, Jennifer Song, Christian Reich, Charalynn Harris, Sandia Akhtar, Robin Clifford, Nandini Selvam, Jennifer L. Pigoga, Yixin Jiao, Yoganand Chillarige, Thomas MaCurdy, Richard Forshee, Steven A. Anderson
Publikováno v:
Vaccine. 40:6481-6488
Active monitoring of safety outcomes following COVID-19 vaccination is critical to understand vaccine safety and can provide early detection of rare outcomes not identified in pre-licensure trials. We present findings from an early warning rapid surv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83f45f224befa1e313aefa58c7c9a7ec
https://doi.org/10.1016/j.vaccine.2022.09.060
https://doi.org/10.1016/j.vaccine.2022.09.060
Autor:
Heng-Ming Sung, Bradley Lufkin, Hector S. Izurieta, Jeffrey A. Kelman, Michael Wernecke, Kathleen Dooling, Yoganand Chillarige, Paula Ehrlich Agger, Yun Lu, Ruth Link-Gelles, Richard A. Forshee, Thomas MaCurdy, Xiyuan Wu
Publikováno v:
Clinical Infectious Diseases. 73:941-948
BackgroundShingrix (recombinant zoster vaccine) was licensed to prevent herpes zoster, dispensed as 2 doses given 2–6 months apart among adults aged ≥50 years. Clinical trials yielded efficacy of >90% for confirmed herpes zoster, but post-market
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2f725afeaf8c5b6f37e547d9b6b8706
https://doi.org/10.1093/cid/ciab125
https://doi.org/10.1093/cid/ciab125
Autor:
SILVIA PEREZ-VILAR, ANDREW MOSHOLDER, ELIZABETH SMITH, HYESEUNG LEE, ANCHI LO, MARC STONE, AMY R BREHM, KIRA LEISHEAR, ARMEN AVAGYAN, YUEQIN ZHAO, MICHAEL WERNECKE, THOMAS MACURDY, JEFF KELMAN, DAVID J GRAHAM
Publikováno v:
Chest. 162:A1924-A1925
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03ac98a456825ac67b0929f26c205495
https://doi.org/10.1016/j.chest.2022.08.1594
https://doi.org/10.1016/j.chest.2022.08.1594
Autor:
Hui-Lee Wong, Ellen Tworkoski, Cindy Ke Zhou, Mao Hu, Deborah Thompson, Bradley Lufkin, Rose Do, Laurie Feinberg, Yoganand Chillarige, Rositsa Dimova, Patricia C. Lloyd, Thomas MaCurdy, Richard A. Forshee, Jeffrey A. Kelman, Azadeh Shoaibi, Steven A. Anderson
Publikováno v:
Vaccine. 41(2)
Monitoring safety outcomes following COVID-19 vaccination is critical for understanding vaccine safety especially when used in key populations such as elderly persons age 65 years and older who can benefit greatly from vaccination. We present new fin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::931436a0fa209537202fd3d719184dea
https://pubmed.ncbi.nlm.nih.gov/36496287
https://pubmed.ncbi.nlm.nih.gov/36496287
Autor:
Laurie Feinberg, Binglie Luo, Sriniketh Nagavarapu, Daniel Moran, Sam Bounds, Thomas MaCurdy, Aimée-Sandrine Uwilingiyimana, Nirmal Choradia, Rose Do, Alexander T. Sandhu, Derek Fenson, Joyce Lam, Jay Bhattacharya
Publikováno v:
Health Affairs. 39:1495-1503
Medicare’s Merit-based Incentive Payment System (MIPS) includes episode-based cost measures that evaluate Medicare expenditures for specific conditions and procedures. These measures compare clinic...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d710a99035931d902e7db9f555aa8b99
https://doi.org/10.1377/hlthaff.2020.00440
https://doi.org/10.1377/hlthaff.2020.00440
Autor:
Yun, Lu, Yoganand, Chillarige, Hector S, Izurieta, Yuqin, Wei, Wenjie, Xu, Michael, Lu, Heng-Ming, Sung, Arnstein, Lindaas, Michael, Wernecke, Thomas, Macurdy, Jeffrey, Kelman, Richard A, Forshee
Publikováno v:
The Journal of Infectious Diseases. 220:1511-1520
BackgroundStudies have found that the high-dose influenza vaccine has a higher relative vaccine effectiveness (RVE) versus standard-dose vaccines in some seasons. We evaluated the effect of age on the RVE of high-dose versus standard-dose influenza v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8742c8540daa6c3fd221f8cdf047c58
https://doi.org/10.1093/infdis/jiz360
https://doi.org/10.1093/infdis/jiz360
Autor:
Hui-Lee Wong, Ellen Tworkoski, Cindy Ke Zhou, Mao Hu, Deborah Thompson, Bradley Lufkin, Rose Do, Laurie Feinberg, Yoganand Chillarige, Rositsa Dimova, Patricia Lloyd, Thomas MaCurdy, Richard A. Forshee, Jeffrey Kelman, Azadeh Shoaibi, Steven A. Anderson
Publikováno v:
SSRN Electronic Journal.
BackgroundMonitoring safety outcomes following COVID-19 vaccination is critical for understanding vaccine safety especially when used in key populations such as elderly persons age 65 years and older who can benefit greatly from vaccination. We prese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bea184d044ee10a8512da61b6283679d
https://doi.org/10.2139/ssrn.3975359
https://doi.org/10.2139/ssrn.3975359
Autor:
Alexander T, Sandhu, Jay, Bhattacharya, Joyce, Lam, Sam, Bounds, Binglie, Luo, Daniel, Moran, Aimée-Sandrine, Uwilingiyimana, Derek, Fenson, Nirmal, Choradia, Rose, Do, Laurie, Feinberg, Thomas, MaCurdy, Sriniketh, Nagavarapu
Publikováno v:
Health affairs (Project Hope). 39(9)
Medicare's Merit-based Incentive Payment System (MIPS) includes episode-based cost measures that evaluate Medicare expenditures for specific conditions and procedures. These measures compare clinicians' cost performance and, along with other MIPS cat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1bfc39fab8cc77666d3b80aa7927797c
https://pubmed.ncbi.nlm.nih.gov/32897780
https://pubmed.ncbi.nlm.nih.gov/32897780